•  
  •  
  •  
  •  

2025-08-09 00:09:16

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group

Keywords Selected:  Mastek

Research

  • Company Update - Mastek Ltd - ICICI Direct
  • Mastek - Growth challenged - HDFC Securities
  • Reports by Anand Rathi : Mastek - Weak Q3 but order backlog reflects increasing momentum; Buy
  • Mastek - Less dependence on UK, currency headwinds abating: retaining a Buy
  • Company Update - Mastek Ltd - ICICI Direct
  • Q3FY22 Company Update - Mastek Ltd - ICICI Direct
  • Company Update - Mastek Ltd - ICICI Direct
  • Maintain BUY on Mastek - Minor misses, recovery underway - HDFC Securities

Stock Report

  • Mastek Ltd Q1 FY2025-26 consolidated net profit jumps to Rs. 92.05 crores
  • Mastek Launches ADOPT.AI to Elevate Gen AI Innovation and Scale Enterprise AI Adoption
  • Mastek Awarded NHS England Contract for Board and SIRO Cybersecurity Training
  • Mastek appoints Raghavendra Jha as Chief Financial Officer
  • Mastek Ltd consolidated Q4 FY2024-25 net profit lower at Rs. 81.07 crores
  • Mastek Ltd recommends final dividend of Rs. 16
  • Mastek continues its commitment to Sustainability and Social Impact through Philanthropy and CSR Initiatives
  • Mastek's Project Deep Blue Marks a Decade of Nurturing Future Innovators
  • Mastek Recognized as an 'Industry Mover' in the S&P Global Sustainability Yearbook 2025
  • Mastek Secures Multi-Year, Multi-Million Dollar Contracts from the UK Public Service Department
  • Mastek Ltd Q3FY25 consolidated profit at Rs. 94.71 crores
  • Mastek attains AWS Well Architected Partner Status
  • Mastek named a 'Leader' in the Everest Group's Digital Transformation Services for Mid-market Enterprises PEAK Matrix® Assessment 2024
  • Mastek Partners with Innovaccer to Transform Value-Based Care and improve the Patient Experience
  • Mastek Ltd Q2 FY2024-25 consolidated net profit surges to Rs. 128.65 crores
  • Mastek Founder & Chairman Ashank Desai Honored With The Gold Stevie® Award In 2024 The International Business Awards®
  • Mastek and Onyx Health Announce Strategic Partnership to Accelerate Healthcare Data Interoperability
  • Mastek Honored with Prestigious Award at the 19th Annual 2024 Globee Awards for Technology
  • Mastek Ltd reports consolidated profit of Rs. 71.50 crores in Q1FY25
  • Mastek to Boost CX Management for Manufacturing, Healthcare, BFSI Sector with NVIDIA AI Enterprise
  • Mastek iConniX - Gen AI powered solutions portfolio to enable business model transformation and innovation across industries
  • Mastek Limited board recommends final dividend of Rs. 12
  • Mastek Ltd reports consolidated PAT of Rs. 92.06 crores in Q4 FY24
  • Mastek Wins a New Deal from Yanbu Cement Company

Latest Post

  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024